Several telehealth GLP-1 programs hold prices flat as doses climb, while others raise monthly costs by $50 to $100 per tier. We compared nine providers that do not increase price with dose, calculated true 12-month costs, and identified which structure fits your budget and timeline.

Hit a GLP-1 plateau on semaglutide or tirzepatide? Walk the 7-step diagnostic, the dose-escalation playbook, the semaglutide-to-tirzepatide switch decision, GLP-Squared dual-compound therapy for resistant cases, and the GLP1R/GIPR genetic angle that explains why population-average titration fails some patients.